These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 25246326

  • 1. Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.
    Eskandari F, Talesh GA, Parooie M, Jaafari MR, Khamesipour A, Saberi Z, Abbasi A, Badiee A.
    Exp Parasitol; 2014 Nov; 146():78-86. PubMed ID: 25246326
    [Abstract] [Full Text] [Related]

  • 2. Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis.
    Heravi Shargh V, Jaafari MR, Khamesipour A, Jalali SA, Firouzmand H, Abbasi A, Badiee A.
    Parasitol Res; 2012 Jul; 111(1):105-14. PubMed ID: 22223037
    [Abstract] [Full Text] [Related]

  • 3. Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes.
    Badiee A, Jaafari MR, Khamesipour A.
    Exp Parasitol; 2007 Feb; 115(2):127-34. PubMed ID: 16979165
    [Abstract] [Full Text] [Related]

  • 4. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Exp Parasitol; 2009 Apr; 121(4):362-9. PubMed ID: 19211022
    [Abstract] [Full Text] [Related]

  • 5. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA).
    Firouzmand H, Badiee A, Khamesipour A, Heravi Shargh V, Alavizadeh SH, Abbasi A, Jaafari MR.
    Acta Trop; 2013 Dec; 128(3):528-35. PubMed ID: 23916506
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition.
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):37-44. PubMed ID: 19615870
    [Abstract] [Full Text] [Related]

  • 7. PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.
    Naseri H, Eskandari F, Jaafari MR, Khamesipour A, Abbasi A, Badiee A.
    Parasite Immunol; 2017 Nov 01; 39(11):. PubMed ID: 28921566
    [Abstract] [Full Text] [Related]

  • 8. The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen.
    Badiee A, Khamesipour A, Samiei A, Soroush D, Shargh VH, Kheiri MT, Barkhordari F, Robert Mc Master W, Mahboudi F, Jaafari MR.
    Exp Parasitol; 2012 Dec 01; 132(4):403-9. PubMed ID: 22982807
    [Abstract] [Full Text] [Related]

  • 9. Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis.
    Shargh VH, Jaafari MR, Khamesipour A, Jaafari I, Jalali SA, Abbasi A, Badiee A.
    Vaccine; 2012 Jun 06; 30(26):3957-64. PubMed ID: 22465747
    [Abstract] [Full Text] [Related]

  • 10. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis.
    Tafaghodi M, Eskandari M, Khamesipour A, Jaafari MR.
    Exp Parasitol; 2011 Oct 06; 129(2):107-14. PubMed ID: 21767536
    [Abstract] [Full Text] [Related]

  • 11. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
    Shimizu Y, Takagi H, Nakayama T, Yamakami K, Tadakuma T, Yokoyama N, Kojima N.
    Parasite Immunol; 2007 May 06; 29(5):229-39. PubMed ID: 17430546
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
    Ravindran R, Maji M, Ali N.
    Mol Pharm; 2012 Jan 01; 9(1):59-70. PubMed ID: 22133194
    [Abstract] [Full Text] [Related]

  • 13. Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.
    Lakhal-Naouar I, Koles N, Rao M, Morrison EB, Childs JM, Alving CR, Aronson NE.
    Vaccine; 2019 Jan 14; 37(3):516-523. PubMed ID: 30528328
    [Abstract] [Full Text] [Related]

  • 14. Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice.
    Soudi S, Hosseini AZ, Hashemi SM.
    Parasite Immunol; 2011 Oct 14; 33(10):561-71. PubMed ID: 21781137
    [Abstract] [Full Text] [Related]

  • 15. Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis.
    Mehravaran A, Nasab MR, Mirahmadi H, Sharifi I, Alijani E, Nikpoor AR, Akhtari J.
    Infect Genet Evol; 2019 Jun 14; 70():27-35. PubMed ID: 30738195
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
    Rostamian M, Niknam HM.
    Mol Immunol; 2017 Nov 14; 91():202-208. PubMed ID: 28963929
    [Abstract] [Full Text] [Related]

  • 17. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F, Di Roberto RB, Gillard J, Cousineau B.
    Vaccine; 2012 Aug 24; 30(39):5726-32. PubMed ID: 22814408
    [Abstract] [Full Text] [Related]

  • 18. Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model.
    Jafari I, Heravi Shargh V, Shahryari M, Abbasi A, Jaafari MR, Khamesipour A, Badiee A.
    Immunobiology; 2018 Aug 24; 223(6-7):493-500. PubMed ID: 29317110
    [Abstract] [Full Text] [Related]

  • 19. KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi.
    Gomes R, Teixeira C, Oliveira F, Lawyer PG, Elnaiem DE, Meneses C, Goto Y, Bhatia A, Howard RF, Reed SG, Valenzuela JG, Kamhawi S.
    PLoS Negl Trop Dis; 2012 Aug 24; 6(4):e1610. PubMed ID: 22509423
    [Abstract] [Full Text] [Related]

  • 20. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE, Salomón MC, Celedon V, García Bustos MF, Morea G, Cuello-Carrión FD, Scodeller EA.
    J Microbiol Immunol Infect; 2016 Feb 24; 49(1):24-32. PubMed ID: 24662018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.